BlackRock, Inc. Amends Schedule 13G/A for BIO-RAD LABORATORIES, INC.

BlackRock, Inc. has filed an amendment to its Schedule 13G/A for BIO-RAD LABORATORIES, INC., disclosing ownership of 1,618,123 shares of Class A Stock, representing 7.4% of the total outstanding shares. The filing indicates a decrease of 144,536 shares (-8.2%) compared to the previous report, with the value of the holdings increasing by $76,285,728 (17.93%) to $501,650,492.46. BlackRock, Inc. certifies that the shares were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer. The filing also notes that various persons have the right to receive dividends or proceeds from the sale of the shares, but no single person's interest exceeds 5% of the total outstanding shares.